The effect of CWI on (A) creatinine levels, (B) estimated glomerular filtration rate (eGFR) and correlations between these parameters before (C) and after (D) CWI in young healthy... by Aneta Teległów (9570190)

Subjects:

The effect of CWI on blood levels of (A) thyroid-stimulating hormone (TSH) and (B) testosterone in young healthy males. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of CK, CK-MB and LDH before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of liver profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of renal profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of hormonal parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of electrolyte concentrations before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of lipid profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

The effect of CWI on blood levels of (A) creatine kinase (CK); (B) CK-muscle brain (CK-MB) and (C) lactate dehydrogenase (LDH) in young healthy males. by Aneta Teległów (9570190)

Subjects:

Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

Subjects:

Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

Subjects:

General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

Subjects:

Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

Subjects:

Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

Subjects:

Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

Subjects:

Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

Subjects:

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

Subjects:

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

Subjects:

Isotype control overlays. by Chen Lu (135200)

Subjects: